•$DICE THERAPEUTICS, INC. (DICE.US)$+66.5% (announces "positive" topline data from its Phase 1 clinical trial of DC-806 an oral small molecule antagonist of the pro-inflammatory cytokine IL-17)
•$Albireo Pharma (ALBO.US)$+17.2% (reports positive topline data from Phase 3 Trial of Bylvay (odevixibat) in Alagille Syndrome)
•$SeaSpine (SPNE.US)$+16.7% (Orthofix and SeaSpine (SPNE) to combine in merger of equals to create leading global spine and orthopedics company; issue guidance)
•$Joby Aviation (JOBY.US)$+10.4% (Joby Aviation and Delta (DAL) partner to pioneer home-to-airport transportation)
•$Orthofix Medical (OFIX.US)$-11.7% (Orthofix and SeaSpine (SPNE) to combine in merger of equals to create leading global spine and orthopedics company; issue guidance)